Florfenicol

Florfenicol

SCHEMBL650814

CS(=O)(=O)c1ccc([C@@H](O)[C@@H](CF)NC(=O)C(Cl)Cl)cc1.O=C(O)O

nearest known ligand 0.95

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Florfenicol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.95
CYP3A4 P08684 3/20 0.95
MEN1 O00255 1/20 0.95
KMT2A Q03164 1/20 0.95
TSHR P16473 2/20 0.74
RPLP1 P05386 1/20 0.49
RPLP0 P05388 1/20 0.49
RPS17 P08708 1/20 0.49
RPSA P08865 1/20 0.49
RPS2 P15880 1/20 0.49
RPL35A P18077 1/20 0.49
RPL7 P18124 1/20 0.49
RPL17 P18621 1/20 0.49
RPS4Y1 P22090 1/20 0.49
RPS3 P23396 1/20 0.49
RPS12 P25398 1/20 0.49
RPL13 P26373 1/20 0.49
RPL10 P27635 1/20 0.49
RPL12 P30050 1/20 0.49
RPL9; RPL9P7; RPL9P8; RPL9P9 P32969 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Florfenicol SCHEMBL651770 0.97 LMNA (1.00) LMNACYP3A4MEN1KMT2ATSHR
Florfenicol SCHEMBL29833609 0.97 LMNA (1.00) LMNACYP3A4MEN1KMT2ATSHR
Florfenicol SCHEMBL3030994 0.97 LMNA (1.00) LMNACYP3A4MEN1KMT2ATSHR
Florfenicol SCHEMBL3637832 0.97 LMNA (1.00) LMNACYP3A4MEN1KMT2ATSHR
Florfenicol SCHEMBL49425 0.97 LMNA (1.00) LMNACYP3A4MEN1KMT2ATSHR
Florfenicol SCHEMBL648260 0.96 LMNA (0.93) LMNACYP3A4MEN1KMT2ATSHR
Florfenicol SCHEMBL4634861 0.96 LMNA (0.97) LMNACYP3A4MEN1KMT2ATSHR
Florfenicol SCHEMBL3817292 0.95 LMNA (0.95) LMNACYP3A4MEN1KMT2ATSHR
Florfenicol SCHEMBL651494 0.94 LMNA (0.88) LMNACYP3A4MEN1KMT2ATSHR
SCHEMBL12683654 0.94 LMNA (0.93) LMNACYP3A4MEN1KMT2ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8119667-B2 Carbonates of fenicol antibiotics SCHERING-PLOUGH ANIMAL HEALTH CORPORATION (US) 2012-02-21 US claimed
EP-1966129-B1 CARBONATES OF FENICOL ANTIBIOTICS SCHERING PLOUGH LTD (CH) 2011-08-17 EP claimed
EP-1966129-A2 CARBONATES OF FENICOL ANTIBIOTICS Schering-Plough Ltd. (CH) 2008-09-10 EP claimed
WO-2007079010-A2 CARBONATES OF FENICOL ANTIBIOTICS SCHERING-PLOUGH LTD. (CH) 2007-07-12 WO claimed
US-20070155799-A1 CARBONATES OF FENICOL ANTIBIOTICS INTERVET INC. 2007-07-05 US claimed
US-8119667-B2 Carbonates of fenicol antibiotics SCHERING-PLOUGH ANIMAL HEALTH CORPORATION (US) 2012-02-21 US disclosed
US-8084643-B2 Nitrogen-containing esters of the secondary alcohol group of florfenicol and of its analogs,including salts; veterinary medicine; nonhydrolyzing as needed to maintain the prodrug in aqueous solution in the subjects system until appropriate; cattle drinking water; bovine respiratory disease INTERVET INC. (US) 2011-12-27 US disclosed
EP-1966129-B1 CARBONATES OF FENICOL ANTIBIOTICS SCHERING PLOUGH LTD (CH) 2011-08-17 EP disclosed
EP-2091909-A1 WATER-SOLUBLE PRODRUGS OF FLORFENICOL AND ITS ANALOGS Schering-Plough Ltd. (CH) 2009-08-26 EP disclosed
EP-1966129-A2 CARBONATES OF FENICOL ANTIBIOTICS Schering-Plough Ltd. (CH) 2008-09-10 EP disclosed
US-20080188556-A1 Water-Soluble Prodrugs of Florfenicol and its Analogs SCHERING-PLOUGH ANIMAL HEALTH CORPORATION 2008-08-07 US disclosed
WO-2008076259-A1 WATER-SOLUBLE PRODRUGS OF FLORFENICOL AND ITS ANALOGS SCHERING-PLOUGH LTD. (CH) 2008-06-26 WO disclosed
WO-2007079010-A2 CARBONATES OF FENICOL ANTIBIOTICS SCHERING-PLOUGH LTD. (CH) 2007-07-12 WO disclosed
US-20070155799-A1 CARBONATES OF FENICOL ANTIBIOTICS INTERVET INC. 2007-07-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070155799-A1 CARBONATES OF FENICOL ANTIBIOTICS CYP4F3, TET1, CYP4F2 LMNA 2548/4885CYP3A4 28/4885MEN1 1940/4885
US-20080188556-A1 Water-Soluble Prodrugs of Florfenicol and its Analogs PFAS, ADH5, SI LMNA 2524/4885CYP3A4 15/4885MEN1 2179/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.